Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 137.40
Bid: 138.00
Ask: 138.40
Change: -2.80 (-2.00%)
Spread: 0.40 (0.29%)
Open: 140.00
High: 140.20
Low: 137.40
Prev. Close: 140.20
KIE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

KIER GROUP ANALYST AND INVESTOR SEMINAR

30 Nov 2016 07:00

RNS Number : 4718Q
Kier Group PLC
30 November 2016
 

 

 

KIER GROUP PLC

 

ANALYST AND INVESTOR SEMINAR

 

 

Kier Group plc, a leading property, residential, construction and services group, is today holding a seminar for analysts and investors on the Group's Residential business.

 

The event will include presentations from the Kier team that will explore the Group's Residential offering, with a particular focus on its mixed-tenure housing delivery model. No new material information will be disclosed.

 

The UK housing market continues to face a number of challenges that are leading to a significant imbalance between the supply and demand of affordable housing. Through its Residential division, Kier is working closely with local authorities, registered providers and central government to address these challenges.

The Group offers its clients a broad range of capabilities covering all stages of the housing development process, from feasibility and funding through to building handover, property sales and housing maintenance and management.

With a mixed tenure pipeline of more than £600m providing good revenue visibility for the business over the next three years, the Group is well positioned to assist its clients to develop their portfolios for both private and affordable housing purposes and to deliver the maintenance requirements thereafter.

The analyst and investor seminar will take place at Numis Securities between 10.30am and 12.30pm, and the presentation will be made available on Kier's website thereafter at http://www.kier.co.uk/investor-relations.aspx.

 

- E N D S -

 

Enquiries:

 

Faeth Birch / Daniela Fleischmann (Finsbury) +44 (0)20 7251 3801

Kier press office +44 (0)1767 355903 / +44 (0) 7791 719452

Louise Turner-Smith, Head of Investor Relations, Kier +44 (0)7976 790012

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFEFFWUFMSESF
Date   Source Headline
6th Oct 20232:34 pmRNSAnnual Financial Report
2nd Oct 202311:15 amRNSTotal Voting Rights
22nd Sep 20232:00 pmRNSDirector/PDMR Shareholding
22nd Sep 202310:09 amRNSHolding(s) in Company
20th Sep 20231:42 pmRNSHolding(s) in Company
20th Sep 20231:39 pmRNSDirector/PDMR Shareholding
15th Sep 20234:06 pmRNSDirector/PDMR Shareholding
14th Sep 20232:36 pmRNSDirector/PDMR Shareholding
14th Sep 20237:00 amRNSFull Year Results for the year ended 30 June 2023
8th Sep 20233:45 pmRNSHolding(s) in Company
4th Sep 20233:37 pmRNSAcquisition of rail assets for £9.6 million
31st Aug 202310:35 amRNSNotification of change of director’s details
30th Aug 20233:06 pmRNSHolding(s) in Company
23rd Aug 20237:00 amRNSNotice of FY23 Results and Presentations
21st Aug 20233:16 pmRNSDirector/PDMR Shareholding
28th Jul 202310:07 amRNSHolding(s) in Company
26th Jul 202311:06 amRNSHolding(s) in Company
20th Jul 20236:03 pmRNSDirector/PDMR Shareholding
20th Jul 20237:00 amRNSFull Year 2023 Trading Update
3rd Jul 20233:17 pmRNSTotal Voting Rights
21st Jun 20234:45 pmRNSDirector/PDMR Shareholding
24th May 20237:00 amRNSHS2 Site Visit
19th May 20231:07 pmRNSDirector/PDMR Shareholding
28th Apr 202311:03 amRNSDirector/PDMR Shareholding
20th Apr 20233:32 pmRNSDirector/PDMR Shareholding
4th Apr 20233:31 pmRNSDirectorate Change
30th Mar 20233:25 pmRNSDirectorate Change
27th Mar 20234:30 pmRNSHolding(s) in Company
21st Mar 20234:16 pmRNSDirector/PDMR Shareholding
17th Mar 202310:33 amRNSDirector/PDMR Shareholding
16th Mar 20234:38 pmRNSHolding(s) in Company
10th Mar 20234:06 pmRNSDirector/PDMR Shareholding
9th Mar 20237:00 amRNSHalf-year Report
28th Feb 20234:59 pmRNSHolding(s) in Company
20th Feb 20234:30 pmRNSDirector/PDMR Shareholding
13th Feb 20234:50 pmRNSHolding(s) in Company
1st Feb 202310:12 amRNSTotal Voting Rights
25th Jan 202311:01 amRNSHolding(s) in Company
20th Jan 202310:00 amRNSDirector/PDMR Shareholding
19th Jan 20237:00 amRNSTrading Update
5th Jan 202310:16 amRNSChange of Director's Details
3rd Jan 202311:05 amRNSTotal Voting Rights
3rd Jan 202311:02 amRNSBlock listing Interim Review
20th Dec 20223:26 pmRNSDirector/PDMR Shareholding
15th Dec 20225:15 pmRNSHolding(s) in Company
1st Dec 202210:04 amRNSTotal Voting Rights
22nd Nov 20222:44 pmRNSDirector/PDMR Shareholding
18th Nov 202211:30 amRNSDirector/PDMR Shareholding
17th Nov 20224:51 pmRNSResult of AGM
17th Nov 20227:00 amRNSAGM Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.